Provides methods for the treatment of disorders such as muscle dystrophy, including Duchenne muscular dystrophy (DMD), limb-girdle muscular dystrophy (LGMD), and Becker muscular dystrophy (BMD), via administration of PPAR-gamma agonist. This evidence concerns the gene PPARG and Duchenne muscular dystrophy.